Jean-Philippe Combal | Co-Founder & Chief Executive Officer
Vivet Therapeutics

Jean-Philippe Combal, Co-Founder & Chief Executive Officer, Vivet Therapeutics

Appearances:



Day 1: 17th March 2026 @ 17:30

Panel Discussion: Top Tips for Attracting Investment

Moderator: Rahul Khetan, Venture Associate, UCB Ventures
Ilya Yasny, Partner, LanceBio Ventures
Lior Shaltiel, Chief Executive Officer, NurExone Biologic
Jean-Philippe Combal, Co-Founder & Chief Executive Officer, Vivet Therapeutics
Natalie Johnston, Principal, 4BIO CAPITAL
Victor Hernandez, CSO, Axovia therapeutics
Elena Beltrami, Investment Manager, Biotech Venture Advisors
Simon Waddington, Professor of Gene Therapy, UCL

Day 2: 18th March 2026 @ 13:35

Panel Discussion: Key Learnings for Successful Company Creation and Spinning Out

Moderator: Leigh Brody, Investment Manager, AlbionVC
James Levine, President, Fondation Ipsen
Oliver Spadiut, Head of the Research Area Biochemical Engineering, TU Wien
Pamela Tranter, Head, Translational Research Group (TRO), University College London
Dame Molly Stevens, John Black Professor of Bionanoscience, University of Oxford
Dominic O'Regan, Business Development Consultant & Investor, New Mosaic
Jean-Philippe Combal, Co-Founder & Chief Executive Officer, Vivet Therapeutics
Michael Kyriakides, Principal, Syncona Ltd
last published: 11/Jul/25 11:15 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150